Original Article
Copyright ©2010 Baishideng.
World J Gastroenterol. Mar 7, 2010; 16(9): 1076-1085
Published online Mar 7, 2010. doi: 10.3748/wjg.v16.i9.1076
Figure 6
Figure 6 Effects of CCK-8S, nifedipine and devazepide on ICa-L in PCSMCs. A: Current traces of ICa-L were recorded from -40 mV to +30 mV during 400 ms depolarization; B: CCK-8S enhanced ICa-L in a concentration-dependent manner (EC50 = 3.2 × 10-8 mol/L); CCK-8S (10-7 mol/L) increased ICa-L depolarized from -40 mV to +10 mV (from 60 ± 8 pA to 84 ± 11 pA; n = 8); C: CCK-8S-intensified ICa-L was markedly suppressed by devazepide (10-7 mol/L), nifedipine (10-5 mol/L), TG and BA (10-5 mol/L); D: Current-voltage curves of whole-cell patch clamp under each condition. Compared with control, CCK-8S (10-7 mol/L) significantly enhanced ICa-L, whereas devazepide, nifedipine, TG and BA inhibited ICa-L. aP < 0.05 vs control group (CaPSS).